SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001662252-18-000022
Filing Date
2018-01-24
Accepted
2018-01-24 17:14:42
Documents
69

Document Format Files

Seq Description Document Type Size
1 S-1 rchas1.htm S-1 1506137
2 EX-3.5 ex3_5.htm EX-3.5 14161
3 EX-3.7 ex3_7.htm EX-3.7 15650
4 EX-3.8 ex3_8.htm EX-3.8 27028
5 EX-3.9 ex3_9.htm EX-3.9 57207
6 EX-3.10 ex3_10.htm EX-3.10 14408
7 EX-5.1 ex5_1.htm EX-5.1 10862
8 EX-23.1 ex23_1.htm EX-23.1 4682
9 GRAPHIC image_001.gif GRAPHIC 4993
10 GRAPHIC image_002.gif GRAPHIC 5831
  Complete submission text file 0001662252-18-000022.txt   6750172

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE rcha-20170930.xml EX-101.INS 1157569
12 XBRL SCHEMA FILE rcha-20170930.xsd EX-101.SCH 62867
13 XBRL CALCULATION FILE rcha-20170930_cal.xml EX-101.CAL 48632
14 XBRL DEFINITION FILE rcha-20170930_def.xml EX-101.DEF 220501
15 XBRL LABEL FILE rcha-20170930_lab.xml EX-101.LAB 278359
16 XBRL PRESENTATION FILE rcha-20170930_pre.xml EX-101.PRE 338852
Mailing Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Business Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212 (424) 230-7001
Rich Pharmaceuticals, Inc. (Filer) CIK: 0001504389 (see all company filings)

IRS No.: 463259117 | Fiscal Year End: 0331
Type: S-1 | Act: 33 | File No.: 333-222677 | Film No.: 18546017
SIC: 2834 Pharmaceutical Preparations